{"count": 3, "results": [{"_id": "27391065", "pmid": 27391065, "pmcid": "PMC5226535", "title": "Metformin as a new anti-cancer drug in adrenocortical carcinoma", "journal": "Oncotarget", "authors": ["Poli G", "Cantini G", "Armignacco R", "Fucci R", "Santi R", "Canu L", "Nesi G", "Mannelli M", "Luconi M"], "date": "2016-08-02T00:00:00Z", "doi": "10.18632/oncotarget.10421", "meta_date_publication": "2016 Aug 2", "meta_volume": "7", "meta_issue": "31", "meta_pages": "49636-49648", "score": 50076.145, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as a new anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ drug in @<m>DISEASE_Adrenocortical_Carcinoma</m> @DISEASE_MESH:D018268 @@@adrenocortical carcinoma@@@", "citations": {"NLM": "Poli G, Cantini G, Armignacco R, Fucci R, Santi R, Canu L, Nesi G, Mannelli M, Luconi M. Metformin as a new anti-cancer drug in adrenocortical carcinoma Oncotarget. 2016 Aug 2;7(31):49636-49648. PMID: 27391065", "BibTeX": "@article{27391065, title={Metformin as a new anti-cancer drug in adrenocortical carcinoma}, author={Poli G and Cantini G and Armignacco R and Fucci R and Santi R and Canu L and Nesi G and Mannelli M and Luconi M}, journal={Oncotarget}, volume={7}, number={31}, pages={49636-49648}}"}}, {"_id": "31508193", "pmid": 31508193, "pmcid": "PMC5811989", "title": "Efficacy of oral metformin in a patient with metastatic adrenocortical carcinoma: Examination of mechanisms and therapeutic implications", "journal": "Rare Tumors", "authors": ["Peixoto RD", "Gomes LM", "Sousa TT", "Racy DJ", "Shigenaga M", "Nagourney RA"], "date": "2018-01-31T00:00:00Z", "doi": "10.1177/2036361317749645", "meta_date_publication": "2018", "meta_volume": "10", "meta_issue": "", "meta_pages": "2036361317749645", "score": 50069.836, "text_hl": "Efficacy of oral @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in a @SPECIES_9606 @@@patient@@@ with metastatic @<m>DISEASE_Adrenocortical_Carcinoma</m> @DISEASE_MESH:D018268 @@@adrenocortical carcinoma@@@: Examination of mechanisms and therapeutic implications", "citations": {"NLM": "Peixoto RD, Gomes LM, Sousa TT, Racy DJ, Shigenaga M, Nagourney RA. Efficacy of oral metformin in a patient with metastatic adrenocortical carcinoma: Examination of mechanisms and therapeutic implications Rare Tumors. 2018;10():2036361317749645. PMID: 31508193", "BibTeX": "@article{31508193, title={Efficacy of oral metformin in a patient with metastatic adrenocortical carcinoma: Examination of mechanisms and therapeutic implications}, author={Peixoto RD and Gomes LM and Sousa TT and Racy DJ and Shigenaga M and Nagourney RA}, journal={Rare Tumors}, volume={10}, pages={2036361317749645}}"}}, {"_id": "28801373", "pmid": 28801373, "title": "Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study.", "journal": "Ann Clin Lab Sci", "authors": ["Brown RE", "Buryanek J", "McGuire MF"], "date": "2017-08-01T00:00:00Z", "meta_date_publication": "2017 Aug", "meta_volume": "47", "meta_issue": "4", "meta_pages": "457-465", "score": 50066.44, "text_hl": "\"in vitro\" @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ modulates the @<m>DISEASE_Adrenocortical_Carcinoma</m> @DISEASE_MESH:D018268 @@@ACC@@@ cell model @CELLLINE_CVCL:0458 @@@H295R and 2@@@. ", "citations": {"NLM": "Brown RE, Buryanek J, McGuire MF. Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study. Ann Clin Lab Sci. 2017 Aug;47(4):457-465. PMID: 28801373", "BibTeX": "@article{28801373, title={Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study.}, author={Brown RE and Buryanek J and McGuire MF}, journal={Ann Clin Lab Sci}, volume={47}, number={4}, pages={457-465}}"}}]}